Board Meeting Details
The 271st Board Meeting was held on 26th May 2026, commencing at 5:04 PM IST and concluding at 6:20 PM IST.
Financial Results Summary
Quarterly Performance (Q4 FY26 vs Q4 FY25)
- Revenue from operations: ₹2,873.29 lakhs (vs ₹2,486.78 lakhs in Q4 FY25) - 15.6% increase
- Total Income: ₹2,901.34 lakhs (vs ₹2,510.44 lakhs in Q4 FY25)
- Profit before tax: ₹530.16 lakhs (vs ₹203.53 lakhs in Q4 FY25)
- Net profit: ₹401.53 lakhs (vs ₹435.47 lakhs in Q4 FY25)
- Basic EPS: ₹3.94 (vs ₹4.28 in Q4 FY25)
Annual Performance (FY26 vs FY25)
- Revenue from operations: ₹9,302.90 lakhs (vs ₹8,233.00 lakhs in FY25) - 13.0% increase
- Total Income: ₹9,364.16 lakhs (vs ₹8,389.70 lakhs in FY25)
- Profit before tax: ₹331.74 lakhs (vs loss of ₹803.50 lakhs in FY25) - Turnaround to profit
- Net profit: ₹55.65 lakhs (vs loss of ₹579.98 lakhs in FY25) - Significant improvement
- Basic EPS: ₹0.55 (vs loss per share of ₹5.70 in FY25)
Key Financial Metrics
Income Statement Highlights
- Other Income: ₹61.26 lakhs (FY26) vs ₹156.70 lakhs (FY25)
- Cost of Material Consumed: ₹4,647.60 lakhs (vs ₹3,989.64 lakhs)
- Employee benefit expense: ₹1,299.49 lakhs (vs ₹1,321.86 lakhs)
- Finance cost: ₹213.33 lakhs (vs ₹250.96 lakhs)
- Depreciation: ₹288.64 lakhs (vs ₹414.51 lakhs)
- Power & Fuel: ₹801.24 lakhs (vs ₹811.37 lakhs)
Balance Sheet Position (as at 31st March 2026)
- Total Assets: ₹9,554.92 lakhs
- Current Assets: ₹5,320.09 lakhs (including Inventories: ₹2,883.98 lakhs, Trade Receivables: ₹1,941.05 lakhs)
- Equity Share Capital: ₹1,018.25 lakhs (Face value ₹10 per share)
- Reserves: ₹3,367.30 lakhs
- Current Liabilities: ₹4,697.84 lakhs (including Borrowings: ₹1,785.23 lakhs, Trade Payables: ₹2,627.39 lakhs)
Cash Flow Statement (FY26)
- Cash from operating activities: ₹281.81 lakhs
- Cash used in investing activities: ₹(26.57) lakhs
- Cash used in financing activities: ₹(254.06) lakhs
- Net increase in cash: ₹1.18 lakhs
- Closing cash balance: ₹5.32 lakhs
Dividend Declaration
The Board recommended a final dividend of 10% amounting to ₹1 per equity share of face value ₹10 each for financial year 2025-26.
Management Changes
1. Appointment of Mr. Y.V. Prashanth (DIN: 00345418), Non-Executive Director as Executive Director effective 1st June 2026, subject to member approval at ensuing AGM.
2. Re-appointment of Sri Y.S.R. Venkata Rao (DIN: 00345524) as Managing Director effective 1st May 2027, subject to member approval at ensuing AGM.
Segment Reporting
The company operates predominantly in chemical manufacturing with geographical segmentation:
Revenue Breakdown (FY26)
- Domestic: ₹4,734.39 lakhs (51% of total)
- Export: ₹4,568.51 lakhs (49% of total)
Trade Receivables (as at 31st March 2026)
- Domestic: ₹485.93 lakhs
- Export: ₹1,455.12 lakhs
Additional Notes
- Previous period figures have been regrouped/rearranged for comparability
- Labour code implementation effective 21st November 2025 did not have material impact based on actuarial valuation
- Company manufactures sodium amide, sodium alkoxides, sodium hydride, sodium azide, tetrazoles, amino pyridines, pyridine derivatives, cyclic compounds, fine chemicals, and intermediates for pharmaceuticals and APIs